Placeholder Banner

BIO Statement to the Senate 340B Bipartisan Working Group on Safeguarding and Strengthening 340B

July 28, 2023

In response to a Request for Information (RFI) from the Senate 340B Bipartisan Working Group, BIO submitted detailed commentson the current status of the program and suggestions for improvements.

Download Full Comments Below
Senate 340B RFI FINAL 7.28.23v.6
Discover More
BIO Board Vice Chair and CEO of Amicus Therapeutics testified that the drug price controls in the Inflation Reduction Act harm drug research and development.
BIO joined with other groups in writing House and Senate Agriculture Committee leaders in support of agricultural research (FFAR) funding in the farm bill.